Login

Switch On Your HIV Smarts.

Is Dolutegravir Alone Enough to Control HIV?

Is Dolutegravir Alone Enough to Control HIV?

November 13, 2015, by

Results of studies presented at the European AIDS Conference could lead to simpler, better tolerated, and easier to take regimens for people with difficult-to-treat HIV. Read More

A Close-Up on Facial Fillers

A Close-Up on Facial Fillers

November 12, 2015, by

Mark S. King describes his decision to undergo procedures to reverse the effects of facial lipoatrophy on TheBody.com. Read More

Genvoya: A New Once-Daily Combo HIV Medication

Genvoya: A New Once-Daily Combo HIV Medication

November 6, 2015, by

People taking Stribild will soon have another option with reduced risk of side effects. Read More

Cancer Therapies Give Hope to HIV Cure Research, But Access is Limited

Cancer Therapies Give Hope to HIV Cure Research, But Access is Limited

November 5, 2015, by

Similarities between how cancer cells and HIV-infected cells evade the immune system give scientists hope that cancer therapy can help find a cure for HIV. Read More

People on ART Skip Doses over Concern of Toxic Interactions

People on ART Skip Doses over Concern of Toxic Interactions

November 4, 2015, by

New research shows people with HIV commonly skip ART doses if they believe HIV meds will be toxic when combined with drugs or alcohol. Read More